Announcements Trials
Browse Landscape

Phase

Phase 1 4Phase EARLY_PHASE1 2Phase 2 2Phase NA 1Phase 4 1Phase 3 1

Status

Withdrawn 1Terminated 1Recruiting 1Completed 1

Sponsor Class

OTHER 4

Study Type

Interventional 4

Sponsor

Cancer Type

Tumor-Agnostic 1Sarcoma 1Gynecologic 1Endocrine 1

Conditions

Neoplasms 2Sarcoma 1Pituitary Neoplasms 1Ovarian Neoplasms 1Osteosarcoma 1

Interventions

Cyclophosphamide 416Radiotherapy 276fludarabine 238Gemcitabine 211Cisplatin 203Nivolumab 184pembrolizumab 183Paclitaxel 176Carboplatin 168Magnetic Resonance Spectroscopy 166fludarabine phosphate 156Irinotecan 135Bevacizumab 133Cytarabine 128Specimen Handling 124Capecitabine 124Temozolomide 123Radiosurgery 118Docetaxel 116Biopsy 116Ipilimumab 113Dexamethasone 113Radiation 111Oxaliplatin 110Fluorouracil 110Rituximab 108Etoposide 108Filgrastim 99Lenalidomide 98Everolimus 96

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Phase 1 × OTHER × Pafolacianine × Clear all
NCT06235125 2026-06-05

Cytalux

Ann & Robert H Lurie Children's Hospital of Chicago

Phase 1 Recruiting
10 enrolled
Sarcoma

Sarcoma, Osteosarcoma

NCT02602119 2022-06-28

Intraoperative Imaging of Pulmonary Nodules by OTL38

University of Pennsylvania

Phase 1 Completed
262 enrolled
Tumor-Agnostic

Neoplasms

NCT04941378 2022-06-27

OTL38 Injection (OTL38) for Intra-Operative Imaging of Folate Receptor Positive Ovarian Cancer

Abramson Cancer Center at Penn Medicine

Phase 1 Withdrawn
Gynecologic

Ovarian Neoplasms

NCT02629549 2019-08-06

Intraoperative Imaging of Pituitary Adenomas by OTL

University of Pennsylvania

Phase 1 Terminated
33 enrolled
Endocrine

Neoplasms, Pituitary Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡